Sweden-based Getinge Group announced a definitive agreement to acquire soft tissue reinforcement technology developer Atrium Medical for $680 million.
Atrium will operate as an independent, self-contained unit of Getinge subsidiary Maquet Cardiovascular and will continue to be led by current Atrium president, Trevor Carlton, according to a press release.
"We believe the similarities in our cultures and business focus, coupled with our ability to continue to work independently will allow our sales team, researchers and scientists to further unlock the value of the core technologies that have driven our success to date," Carlton said in prepared remarks.
"The acquisition of Atrium is an excellent strategic fit with our long-term business goals as Atrium’s robust product line complements Maquet Cardiovascular’s existing therapy options and provides additional solutions for the customers that we serve," added Maquet president & CEO Christian Keller.
Late last month Maquet’s Sensation Plus aortic balloon catheter won FDA approval and CE Mark clearance in the European Union.
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.